Studying the effectiveness of furosemide in controlling postpartum blood pressure in patients with preeclampsia and gestational hypertension

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240514061800N11

Enrollment

234

Registered

2026-04-18

Start date

2026-05-22

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia. Supervision of high risk pregnancy

Interventions

Intervention 1: Intervention group: Patients in group A are treated with the drug amlodipine (Kimiya Daru) at a dose of 5 mg per day for five days. Intervention 2: Intervention group: In addition to r

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: No history of heart disease Body mass index below 40 Patients with blood pressure above 150/100 Patients with pregnancy-related hypertension (gestational hypertension and preeclampsia)

Exclusion criteria

Exclusion criteria: Drug allergy Drug side effects due to the use of furosemide

Design outcomes

Primary

Measure	Time frame
Blood pressure measurement. Timepoint: The third, seventh, and sixth weeks after delivery. Method of measurement: Mercury pressure gauge.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Naeiji

Shahid Beheshti University of Medical Sciences

zahrabahman77@yahoo.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026